Home » SEMAFULL (Semaglutide) Injection 15 mg / 3 mL
SEMAFULL (Semaglutide) Injection 15 mg / 3 mL

SEMAFULL (Semaglutide) Injection 15 mg / 3 mL

Weight Loss / Diabetes
Manufacturer : Natco Pharma
Product Code: semafull-a
Availability:
In Stock
Add to Compare
Add to Wish List
Add to Cart
Description

SEMAFULL (Semaglutide) Injection 15 mg / 3 mL

Overview

SEMAFULL (Semaglutide) Injection 15 mg / 3 mL is a high-strength GLP-1 receptor agonist formulation designed to support advanced metabolic management and weight control. Developed as a multi-dose injectable solution, SEMAFULL provides flexibility in dosing and is intended for use under medical supervision. With its concentrated formulation, it is suitable for patients who require higher cumulative dosing as part of a structured treatment plan.

What is Semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a naturally occurring hormone involved in appetite regulation and glucose metabolism. It works by enhancing insulin secretion, reducing glucagon levels, slowing gastric emptying, and promoting a feeling of fullness. These combined actions make semaglutide effective in both glycemic control and weight management protocols.

Product Composition

SEMAFULL contains 15 mg of semaglutide in a 3 mL solution, offering a concentrated multi-dose format. This allows for tailored dosing schedules depending on individual needs and physician guidance. The formulation is designed for subcutaneous administration and ensures stability and consistency across multiple doses.

Key Features

  • High-strength formulation: 15 mg / 3 mL

  • Multi-dose vial or pen configuration (depending on packaging)

  • Flexible dosing options for individualized treatment

  • GLP-1 receptor agonist mechanism

  • Suitable for weekly dosing protocols

  • Designed for metabolic and weight management support

Benefits

SEMAFULL offers a practical solution for individuals requiring sustained GLP-1 therapy. Its concentrated format reduces the need for frequent refills and allows healthcare providers to adjust dosing more precisely. Patients may experience reduced appetite, improved satiety, better blood sugar control, and support for gradual, sustainable weight loss. The long-acting nature of semaglutide also enhances treatment adherence.

Dosage and Administration

SEMAFULL is administered as a subcutaneous injection, typically once weekly. The exact dose depends on the patient’s treatment stage and clinical goals. Patients often begin with lower weekly doses and gradually increase over time to minimize side effects and improve tolerability. Because SEMAFULL is a multi-dose format, careful measurement is required to ensure accurate dosing.

Injection sites include the abdomen, thigh, or upper arm, and rotation of injection sites is recommended. It is important to follow a consistent weekly schedule and adhere strictly to medical guidance when adjusting doses.

Safety and Considerations

SEMAFULL should only be used under the supervision of a qualified healthcare provider. Common side effects may include nausea, mild gastrointestinal discomfort, or appetite changes, particularly during dose escalation phases. Patients with pre-existing conditions or those taking other medications should consult a healthcare professional before starting treatment.

Storage Instructions

Store SEMAFULL in a refrigerator prior to first use. After opening, it may be stored according to recommended guidelines, typically at controlled room temperature for a limited time. Protect from excessive heat, light, and freezing. Always ensure proper handling and hygiene when using multi-dose formats.

Conclusion

SEMAFULL (Semaglutide) Injection 15 mg / 3 mL provides a high-strength, flexible solution for GLP-1 therapy. With its concentrated formulation and adaptable dosing, it is well-suited for structured metabolic and weight management programs requiring precision and consistency.

#{message}